Effect of alvitili on immunological parameters in often ailing children.
The problem of the rehabilitation of often ailing children is not yet elucidated despite of a substantial amount of research done in this field. It is acknowledged that the impairment of immune reactivity is a pathogenetic foundation of often and prolonged respiratory diseases in children. In this connection, the aim of the study was to evaluate the effect of alvitili on the main immunologic parameters in children who get ill frequently. Alvitili, produced by Solvay Pharma (France), is one of the promising vitamin preparations that contain all necessary water-soluble and oil-soluble vitamins. Thirty children 3-8 years of age were selected for the study: 15 children were included in the group of often ailing children and 15 healthy children made the control group. Immunological examination was carried out using standard methods before and after administration of alvitili at a dose of 5 ml 3 times a day for 3 weeks. Alvitili normalized originally decreased levels of T lymphocytes and T helpers, enhanced expression of early activation markers on the surface of T lymphocytes and T helpers, normalized the number of HLA DR(+) T cells and the level of MIF production. The drug stimulated IgM synthesis, expression of FcgammaRIII on the surface of neutrophils and normalized the IgG level. The study showed that alvitili is an effective remedy in the rehabilitation of ill children, since it compensates a vitamin deficiency that is frequently seen in often-ailing children, and it normalizes various immunological parameters.
Sotnikova
Natalia Yu
NY
V.N. Gorodkov State Scientific-Research Institute of Maternity and Childhood, Ivanovo, Russia.
Gromova
Olga A
OA
Kudryashova
Anna V
AV
Vtorushina
Valentina V
VV
D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D002648:Child; D005602:France; D006684:HLA-DR Antigens / Q000276:immunology; D006801:Humans; D013601:T-Lymphocytes / Q000276:immunology
D006684:HLA-DR Antigens